Results 171 to 180 of about 19,748 (246)

Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune-Mediated Thrombocytopenia. [PDF]

J Vet Intern Med
Kennils JM, Wilson HE.
europepmc   +1 more source

Next-generation Bruton's tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report. [PDF]

Ann Hematol
Chen L, Huang Y, Xu J, Huang S, Zhang Q, Hua F, Pan X, Mi JQ.   +7 more
europepmc   +1 more source

Evaluation of non-covalent interactions of chlorambucil (monomer and dimer) and its interaction with biological targets: Vibrational frequency shift, electron density topological and automated docking analysis

, 2017
T. Karthick, Poonam Tandon, K.S. Srivastava, Swapnil Singh   +3 more
openalex   +1 more source

Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone Lymphoma. [PDF]

J Hematol
Kwan RLY, Lim RMH, Chan JY.
europepmc   +1 more source

Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors. [PDF]

Blood Res
Hur JY, Lee JH, Lee JH, Park HS, Park H, Choi Y, Choi JH, Won YW, Yoon SE, Kim WS, Kim SJ.   +10 more
europepmc   +1 more source

Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population. [PDF]

Hemasphere
Ghia P, Ysebaert L, Janssens A, Stilgenbauer S, Fouad M, Schioppa CA, Hernández-Rivas JÁ, Tedeschi A.   +7 more
europepmc   +1 more source

Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg- negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia

, 2008
Sungmin IM, 장정원, 김병욱, 최황, 최규용, 박수정, 한치화   +6 more
openalex   +1 more source

Ugi reaction in the synthesis of Janus dendrimers as nanocarriers of chlorambucil and ibuprofen

Israel Barajas‐Mendoza, Teresa Ramírez‐Ápan, Marcos Martínez‐García   +2 more
openalex   +1 more source

Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia [PDF]

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak, Alan P Skarbnik, John M. Pagel, Ian W. Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutré, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A. Woyach, Emmanuelle Ferrant, William G. Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, John C. Byrd   +26 more
openalex   +1 more source

Zanubrutinib as a salvage therapy for ibrutinib-resistant chronic lymphocytic leukemia: a case report. [PDF]

Front Oncol
Lv Z, Lu P, Jing C, Yi X, Wu X.
europepmc   +1 more source